Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 8, 1997, Pages 2396-2402

  Labrie, Fernand ^a   Bélanger, Alain ^b   Cusan, Lionel ^b   Gomez, José Luis ^b   Candas, Bernard ^b  

^a LAVAL UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTENEDIOL; ANDROSTENEDIONE; ANDROSTERONE; HORMONE PRECURSOR; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; PREGNENOLONE DERIVATIVE; SEX HORMONE; TESTOSTERONE;

ADRENAL GLAND; ADULT; AGED; AGING; ANDROGEN METABOLISM; ARTICLE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OVARY FUNCTION; PRIORITY JOURNAL; TESTIS FUNCTION; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE;

EID: 0030739131     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.8.4160     Document Type: Article

References (36)

1. Bélanger A, Candas B, Dupont A, et al. 1994 Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab. 79:1086-1090.
2. Migeon CJ, Keller AR, Lawrence B, Shepart, II, TH. 1957 Dehydroepiandrosterone and androsterone levels in human placenta. Effect of age and sex: day-to-day and diurnal variations. J Clin Endocrinol Metab. 17:1051-1062.
3. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:551-555.
4. Labrie F. 1991 Intracrinology. Mol Cell Endocrinol. 78:C113-C118.
5. Labrie F, Bélanger A, Simard J, Luu-The V, Labrie C. 1995 DHEA and peripheral androgen and estrogen formation: intracrinology. Ann NY Acad Sci. 774:16-28.
6. Bélanger B, Bélanger A, Labrie F, et al. 1989 Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J Steroid Biochem. 32:695-698.
7. Labrie F, Dupont A, Bélanger A. 1985 Complete androgen blockade for the treatment of prostate cancer. Important Adv Oncol. 00:193-217.
8. Labrie C, Bélanger A, Labrie F. 1988 Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology. 123:1412-1417.
9. Labrie F, Simard J, Luu-The V, et al. 1996 The 3β-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. In: Hansson, V, Levy, FO, Taskén, K (eds) Signal Transduction in Testicular Cells. Ernst Schering Research Foundation Workshop. Berlin: Springer-Verlag, vol 2[Suppl]:185-218.
10. Rhéaume E, Simard J, Morel Y, et al. 1992 Congenital adrenal hyperplasia due to point mutations in the type H 3β-hydroxysteroid dehydrogenase deficiency. Nature Genet. 1:239-245.
11. Labrie F, Sugimoto Y, Luu-The V, et al. 1992 Structure of human type II 5α-reductase. Endocrinology. 131:1571-1573.
12. Labrie F, Simard J, Luu-The V, Bélanger A, Pelletier G. 1992 Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase / 5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J Steroid Biochem Mol Biol. 43:805-826.
13. Luu-The V, Zhang Y, Poirier D, Labrie F. 1995 Characteristics of human types 1, 2 and 3 17β-hydroxysteroid dehydrogenase activities: oxidation-reduction and inhibition. J Steroid Biochem Mol Biol. 55:581-587.
14. Labrie Y, Durocher F, Lachance Y, et al. 1995 The human type II 17β-hydroxysteroid dehydrogenase gene encodes two alternatively-spliced messenger RNA species. DNA Cell Biol. 14:849-861.
15. Bélanger A, Brochu M, Cliche J. 1986 Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab. 62:812-815.
16. Labrie F, Bélanger A, Dupont A, et al. 1993 Science behind total androgen blockade: from gene to combination therapy. Clin Invest Med. 16:475-492.
17. Bélanger A, Labrie F, Dupont A, Brochu M, Cusan L. 1988 Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma. Clin Invest Med. 11:321-326.
18. Bélanger A, Caron S, Picard V. 1980 Simultaneous radioimmunoassay of progestins, androgens, and estrogens in adult rat testis. J Steroid Biochem. 13:185-190.
19. Bélanger A, Labrie F, Angeli A. 1990 Unconjugated and glucuronide steroid levels in human breast cyst fluid. Ann NY Acad Sci. 586:93-100.
20. Rodbard D. 1974 Apparent positive cooperative effect in cyclic AMP and corticosteroid production by isolated adrenal cells in response to ACTH analogs. Endocrinology. 94:1427-1437.
21. Kramer CY. 1956 Extension of multiple range tests to group means with unique numbers of replications. Biometrics. 12:307-310.
22. Luu-The V, Lachance Y, Labrie C, et al. 1989 Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol. 3:1310-1312.
23. Vermeulen A. 1991 Clinical review 24: Androgens in the aging male. J Clin Endocrinol Metab. 73:221-224.
24. Gray A, Feldman HA, McKinlay JB, Longcope C. 1991 Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts male aging study. J Clin Endocrinol Metab. 73:1016-1025.
25. Labrie F, Dupont A, Bélanger A, et al. 1986 Treatment of prostate cancer with gonadotropin-releasing hormone agonists. Endocr Rev. 7:67-74.
26. Steingold K, De Ziegler D, Cedars M, et al. 1987 Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. J Clin Endocrinol Metab. 65:773-778.
27. Studd JW, Chakravarti S, Collins WP. 1978 Plasma hormone profiles after the menopause and bilateral oophorectomy. Postgrad Med J. 54:25-30.
28. Longcope C, Hui SL, Johnston, Jr, CC. 1987 Free estradiol, tree testosterone, and sex hormone-binding globulin in perimenopausal women. J Clin Endocrinol Metab. 64:513-518.
29. Steinberg KK, Freni-Titulaer LW, DePuey EG, et al. 1989 Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 69:533-539.
30. Dennefors BL, Janson PO, Knutson F, Hamberger L. 1980 Steroid production and responsiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries. Am J Obstet Gynecol. 136:997-1002.
31. Lucisano A, Russo N, Acampora MG, et al. 1986 Ovarian and peripheral androgen and oestrogen levels in post-menopausal women; correlations with ovarian histology. Maturitas. 8:57-65.
32. Brochu M, Bélanger A. 1987 Increase in plasma steroid glucuronide levels in men from infancy to adulthood. J Clin Endocrinol Metab. 64:1283-1287.
33. Mauvais-Jarvis P, Charransol G, Bobas-Masson F. 1973 Simultaneous determination of urinary androstanediol and testosterone as an evaluation of human androgenicity. J Clin Endocrinol Metab. 36:452-455.
34. Moghissi E, Ablan F, Horton R. 1984 Origin of plasma androstanediol glucuronide in men. J Clin Endocrinol Metab. 59:417-421.
35. Chesnut CH, Ivey JL, Gruber HE, et al. 1983 Stanozolol in postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism. 32:571-580.
36. Rosen HN, Tollin S, Balena R, et al. 1995 Bone density is normal in male rats treated with finasteride. Endocrinology. 136:1381-1387.